Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Mental Health and Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
Psychiatry Res. 2021 Oct;304:114145. doi: 10.1016/j.psychres.2021.114145. Epub 2021 Jul 29.
The literature on the application of repetitive transcranial magnetic stimulation (rTMS) in Borderline Personality Disorder (BPD) is unclear, even though its neuromodulatory effects on underlying neural circuitry involved in BPD symptoms suggest that it could be a potential treatment option. We sought to review the evidence on rTMS as a treatment option in BPD. PubMed (for Medline database), Google Scholar, and Scopus were systematically searched following the PRISMA guidelines for studies of any design examining the application of the rTMS treatment in adult patients with precise and primary diagnosis of BPD written in the English language. The systematic review has been registered on PROSPERO (CRD42020215927). Forty one records were screened, and eight fulfilled inclusion criteria (total of 63 patients). The existing studies suggest that rTMS is a well-tolerated treatment in patients with BPD. Double-blind randomized controlled studies are necessary to help elucidate the effects of rTMS in the different symptoms in BPD and establish efficacy and the best cortical targets and stimulation protocols. Longitudinal studies that combine evidenced based psychotherapy with rTMS may be a future line of investigation that could potentially improve outcomes for this population.
重复经颅磁刺激(rTMS)在边缘型人格障碍(BPD)中的应用文献尚不清楚,尽管其对 BPD 症状相关神经回路的神经调节作用表明它可能是一种潜在的治疗选择。我们旨在综述 rTMS 作为 BPD 治疗选择的证据。根据 PRISMA 指南,我们对任何设计的研究进行了系统检索,这些研究检查了 rTMS 治疗在成人 BPD 患者中的应用,这些患者的 BPD 诊断准确且为原发性,且研究报告均为英文。本系统评价已在 PROSPERO(CRD42020215927)上注册。共筛选出 41 条记录,其中 8 条符合纳入标准(共 63 例患者)。现有研究表明,rTMS 是 BPD 患者耐受良好的治疗方法。需要进行双盲随机对照研究,以帮助阐明 rTMS 在 BPD 不同症状中的作用,并确定疗效和最佳皮质靶点及刺激方案。将基于证据的心理治疗与 rTMS 相结合的纵向研究可能是未来的研究方向,这可能会改善该人群的治疗效果。